Adagene (ADAG) Receivables - Other (2019 - 2025)
Adagene's (ADAG) quarterly Receivables - Other came in at $17.3 billion in Q4 2025, up 108.8% year-on-year from $8.3 billion in Q4 2024, and up 296057920.48% on a QoQ basis from $5860.0 in Q2 2025.
Adagene (ADAG) Receivables - Other (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Receivables - Other data on file, last reported at $17.3 billion in Q4 2025.
- On a quarterly basis, Receivables - Other rose 108.8% year-over-year to $17.3 billion in Q4 2025; TTM through Dec 2025 was $17.3 billion, a 108.8% increase from a year earlier, with the FY2025 full-year figure at $17.3 billion, up 108.8% from the prior year.
- Receivables - Other for Q4 2025 stood at $17.3 billion, up from $5860.0 in the prior quarter.
- Over the last five years, Receivables - Other for ADAG reached as high as $1870.1 billion in Q2 2022 and fell as low as $5860.0 in Q2 2025.
- Historically, Receivables - Other has averaged $313.1 billion across 5 years, with a median of $12.8 billion in 2024.
- Across the five-year window, Receivables - Other surged 201428797.64% in 2022 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Receivables - Other stood at $4.5 million in 2021, then soared by 13744682.73% to $619.4 billion in 2022, then sank by 64.16% to $222.0 billion in 2023, then tumbled by 96.26% to $8.3 billion in 2024, then soared by 108.8% to $17.3 billion in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $17.3 billion in Q4 2025, $5860.0 in Q2 2025, and $8.3 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.35 Bn |
| Dec 31, 2025 | 17.35 Bn |
| Jun 30, 2025 | 5,860.00 |
| Jun 30, 2025 | 5,860.00 |
| Dec 31, 2024 | 8.31 Bn |
| Dec 31, 2024 | 8.31 Bn |
| Jun 30, 2024 | 190,608.00 |
| Jun 30, 2024 | 190,608.00 |
| Dec 31, 2023 | 222.03 Bn |
| Dec 31, 2023 | 222.03 Bn |
| Jun 30, 2023 | 393.97 Bn |
| Jun 30, 2023 | 393.97 Bn |
| Dec 31, 2022 | 619.43 Bn |
| Dec 31, 2022 | 619.43 Bn |
| Jun 30, 2022 | 1,870.08 Bn |
| Jun 30, 2022 | 1,870.08 Bn |
| Dec 31, 2021 | 4.51 Mn |
| Dec 31, 2021 | 4.51 Mn |
| Jun 30, 2021 | 928,408.00 |
| Jun 30, 2021 | 928,408.00 |